Omega Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Omega Therapeutics (OMGAQ) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Omega Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Omega Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Omega Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $374 | 503 | 0.75 |
| 2024-09-30 | $614 | 503 | 1.22 |
| 2024-06-30 | $1.0k | 504 | 2.00 |
| 2024-03-31 | $37k | 10k | 3.65 |
| 2023-12-31 | $48k | 16k | 3.01 |
| 2023-09-30 | $56k | 26k | 2.15 |
| 2023-06-30 | $119k | 21k | 5.60 |
| 2023-03-31 | $10k | 1.7k | 5.94 |
| 2022-12-31 | $9.0k | 1.6k | 5.78 |
| 2022-06-30 | $7.0k | 1.9k | 3.68 |
| 2022-03-31 | $113k | 18k | 6.22 |
| 2021-12-31 | $102k | 9.0k | 11.30 |
Top funds holding Omega Therapeutics
View all funds holding Omega Therapeutics